http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-774287-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2001-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd21c17713e76175205c689af528bac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713b12276be4f7c0d3bdbc49df960d5b |
| publicationDate | 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-774287-B2 |
| titleOfInvention | Immunoconjugate compositions and methods for cancer treatment by selectively inhibiting VEGF |
| priorityDate | 1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2880.